![Yann Mazabraud](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yann Mazabraud
Företagsledare/Principal på
RHYTHM PHARMACEUTICALS, INC.
Förmögenhet: 6 M $ per 2026-07-31
Profil
Yann Mazabraud is Executive Vice President & Head-International at Rhythm Pharmaceuticals, Inc. since 2020.
Former roles include General Manager-US & Head-North America at Genzyme Corp.
from 2016 to 2017, Head-Latin America at Genzyme Therapeutics Ltd., and Chief Commercial Officer & Head-International at Trevi Therapeutics, Inc. from 2017 to 2020.
Education includes a graduate degree from Groupe de Sup de Co La Rochelle.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-08-12 | 55 655 ( 0,08 % ) | 6 M $ | 2026-07-31 |
Aktiva positioner av Yann Mazabraud
| Företag | Position | Start |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Företagsledare/Principal | 2020-10-05 |
Tidigare kända positioner av Yann Mazabraud
| Företag | Position | Slut |
|---|---|---|
| TREVI THERAPEUTICS, INC. | Företagsledare/Principal | 2020-10-03 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Företagsledare/Principal | 2017-10-01 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Företagsledare/Principal | - |
Yann Mazabrauds utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
52
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Rhythm Pharmaceuticals, Inc.
 Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases | Health Technology |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Health Technology |
Groupe de Sup de Co La Rochelle
 Groupe de Sup de Co La Rochelle Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trevi Therapeutics, Inc.
 Trevi Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treatment for cough conditions | Health Technology |
